《业绩》永泰生物(06978.HK)全年亏损扩至2.31亿人民币

阿斯达克财经
Yesterday

永泰生物-B(06978.HK) 公布2025年度业绩,其他收入录得2,051万人民币(下同),按年下降39.3%。亏损由上年度1.87亿元,扩至2.31亿元,每股亏损42分。不派末期息。(de/d)(港股报价延迟最少十五分钟。)过往派息公布日期派息事项派息内容2025/09/19特别业绩供股: 5股供1股@港元 2.50002025/08/20中期业绩无派息2025/03/31末期业绩无派息...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10